Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

oncology: GU

  • <sup>68</sup>Ga-PSMA-11 PET/MRI in Patients with Newly Diagnosed Intermediate- or High-Risk Prostate Adenocarcinoma: PET Findings Correlate with Outcomes After Definitive Treatment
    You have access
    68Ga-PSMA-11 PET/MRI in Patients with Newly Diagnosed Intermediate- or High-Risk Prostate Adenocarcinoma: PET Findings Correlate with Outcomes After Definitive Treatment
    Farshad Moradi, Heying Duan, Hong Song, Guido A. Davidzon, Benjamin I. Chung, Alan E. C. Thong, Andreas M. Loening, Pejman Ghanouni, Geoffrey Sonn and Andrei Iagaru
    Journal of Nuclear Medicine December 1, 2022, 63 (12) 1822-1828; DOI: https://doi.org/10.2967/jnumed.122.263897
  • You have access
    The added value of 18F-FDG PET/CT compared to 68Ga-PSMA PET/CT in patients with castration-resistant prostate cancer
    Ruohua Chen, Yining Wang, Yinjie Zhu, Yiping Shi, Lian Xu, Gang Huang and Jianjun Liu
    Journal of Nuclear Medicine April 23, 2021, jnumed.121.262250; DOI: https://doi.org/10.2967/jnumed.121.262250
  • Open Access
    68Ga-PSMA-11 NDA Approval: A Novel and Successful Academic Partnership
    Giuseppe Carlucci, Robin Ippisch, Roger Slavik, Ashley Mishoe, Joseph Blecha and Shaojun Zhu
    Journal of Nuclear Medicine February 1, 2021, 62 (2) 149-155; DOI: https://doi.org/10.2967/jnumed.120.260455
  • You have access
    68Ga-PSMA-HBED-CC Uptake in Cervical, Celiac, and Sacral Ganglia as an Important Pitfall in Prostate Cancer PET Imaging
    Christoph Rischpler, Teresa I. Beck, Shozo Okamoto, Anna M. Schlitter, Karina Knorr, Markus Schwaiger, Jürgen Gschwend, Tobias Maurer, Philipp T. Meyer and Matthias Eiber
    Journal of Nuclear Medicine September 1, 2018, 59 (9) 1406-1411; DOI: https://doi.org/10.2967/jnumed.117.204677
  • You have access
    68Ga-PSMA-11 PET Imaging of Response to Androgen Receptor Inhibition: First Human Experience
    Thomas A. Hope, Charles Truillet, Eric C. Ehman, Ali Afshar-Oromieh, Rahul Aggarwal, Charles J. Ryan, Peter R. Carroll, Eric J. Small and Michael J. Evans
    Journal of Nuclear Medicine January 1, 2017, 58 (1) 81-84; DOI: https://doi.org/10.2967/jnumed.116.181800
  • You have access
    (2S)-2-(3-(1-Carboxy-5-(4-211At-Astatobenzamido)Pentyl)Ureido)-Pentanedioic Acid for PSMA-Targeted α-Particle Radiopharmaceutical Therapy
    Ana P. Kiess, Il Minn, Ganesan Vaidyanathan, Robert F. Hobbs, Anders Josefsson, Colette Shen, Mary Brummet, Ying Chen, Jaeyeon Choi, Eftychia Koumarianou, Kwamena Baidoo, Martin W. Brechbiel, Ronnie C. Mease, George Sgouros, Michael R. Zalutsky and Martin G. Pomper
    Journal of Nuclear Medicine October 1, 2016, 57 (10) 1569-1575; DOI: https://doi.org/10.2967/jnumed.116.174300
  • You have access
    Evaluation of Castration-Resistant Prostate Cancer with Androgen Receptor–Axis Imaging
    Neeta Pandit-Taskar, Darren R. Veach, Josef J. Fox, Howard I. Scher, Michael J. Morris and Steven M. Larson
    Journal of Nuclear Medicine October 1, 2016, 57 (Supplement 3) 73S-78S; DOI: https://doi.org/10.2967/jnumed.115.170134
SNMMI

© 2025 SNMMI

Powered by HighWire